The number of patients with metastatic non-small cell lung cancer eligible for subsidised treatment with pembrolizumab is set to triple, the federal Minister for Health, Greg Hunt, has announced.

In a move expected to benefit 4000 Australians with advanced disease, he has approved two new PBS indications and loosened restrictions on an existing indication.